Study identifies liver–metabolic disease as a key risk factor for heart failure in older adults with atrial fibrillation

Atrial fibrillation (AFib) is the most common cardiac arrhythmia worldwide and a major contributor to heart failure (HF), affecting over 64 million people globally. Steatotic liver disease (SLD) encompasses a spectrum of liver disorders characterized by excessive fat accumulation in the liver, including metabolic dysfunction-associated SLD (MASLD), MASLD with increased alcohol intake (MetALD), and alcoholic liver disease (ALD).

This article was originally published on MedicalXpress.com

You may also be interested in:

Read More:

Lawyers Lookup